Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Biotech
Lilly inks $2.5B Scorpion buyout in twist to breast cancer tale
Lilly is reenergizing its attempt to challenge Novartis and Roche with a deal to buy Scorpion’s PI3Kα pipeline for up to $2.5 billion.
Nick Paul Taylor
Jan 13, 2025 9:55am
Blueprint halts CDK2 inhibitor but pushes on in breast cancer
Jan 13, 2025 5:43am
Bayer’s hot flash drug hits goal in phase 3 breast cancer trial
Jan 9, 2025 7:40am
Lilly's oral SERD Ember counts on Verzenio to broaden its glow
Dec 11, 2024 8:15am
PreciseDx's breast tumor pathology AI measures up to DNA testing
Dec 6, 2024 9:00am
GE HealthCare debuts AI-powered, zero-click mammography system
Dec 2, 2024 9:30am
